| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $117.0M | +4.5% |
| R&D Expense | $340.0M | +18.1% |
| SG&A Expense | $117.0M | +12.5% |
| Operating Income | -$340.0M | -21.4% |
| Pre-tax Income | -$301.0M | -13.2% |
| Income Tax | $6.0M | +500.0% |
| Net Income | -$307.0M | -15.0% |
| EPS (Basic) | -$4.15 | -11.9% |
| EPS (Diluted) | -$4.15 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $127.0M | -38.3% |
| Current Assets | $831.0M | -22.1% |
| Total Assets | $1.09B | -18.6% |
| Current Liabilities | $184.0M | -4.7% |
| Stockholders' Equity | $462.0M | -29.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$306.0M | -169.9% |
| Capital Expenditures | $24.0M | +300.0% |
| Investing Cash Flow | $194.0M | +147.0% |
| Financing Cash Flow | $33.0M | +0.0% |
| Free Cash Flow | -$330.0M | -176.4% |
| -11.9% |